MedTrace Logo

Minimally Invasive Surgery (MIS) for Spine Metastases

NCT02367378 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2017-06-20

No results posted yet for this study

Summary

The purpose of this study is to collect information on the effect of minimally invasive spine tumor decompression on treated patients. This treatment option is less invasive that the standard surgical decompression and is expected to result in better wound healing, decreased tissue trauma, and decreased pain after surgery.

Conditions

  • Spine Metastases

Sponsors & Collaborators

Principal Investigators

  • Arthur Jenkins, MD · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-06-13
Completion
2016-06-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02367378 on ClinicalTrials.gov